| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 5, 2024
Strong momentum to continue in 2024 as SOPHiA GENETICS announces record revenue, 35 new customer additions in Q4, and 36% cash burn decline in FY 2023 BOSTON and ROLLE, Switzerland, March 05, 2024...
-
Feb 7, 2024
SOPHiA GENETICS and AstraZeneca Spain expand HRD testing program to support molecular diagnosis of ovarian cancer in Spain BOSTON and ROLLE, Switzerland and MADRID , Feb. 7, 2024 /PRNewswire/ --...
-
Jan 25, 2024
The company announced Bioma4me has implemented SOPHiA DDM™ to support its rare disorder testing capabilities BOSTON and ROLLE, Switzerland , Jan. 25, 2024 /PRNewswire/ -- SOPHiA GENETICS...
-
Jan 18, 2024
RareCyte will use the SOPHiA DDM™ Platform to support its oncology testing panel BOSTON and ROLLE, Switzerland , Jan. 18, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native...
-
Jan 14, 2024
SOPHiA GENETICS technology helps advance cancer research across India SOPHiA GENETICS and Karkinos Healthcare join forces to propel cutting-edge genomic solutions for breakthroughs in personalized...
General Inquiries
SOPHiA GENETICS
La Pièce 12, CH-1180
Rolle, Switzerland
+41 21 694 10 60
Transfer Agent
Computershare Trust Company, N.A.
Courier Delivery:
P.O. Box 43006
Providence RI 02940-3006
Overnight Delivery:
150 Royall St. STE 101
Canton, MA 02021
877.373.6374
www.computershare.com